Urologists, oncologists, radiologists, and pathologists collaborate on every urology case including prostate, kidney, and bladder cancer at SMC's Urologic Cancer Center.
Yes. Submit your biopsy results, MRI, CT scans, PSA history, or other relevant investigations through My 1Health before you travel. The SMC urology and oncology team confirms whether treatment is appropriate. Video consultations are available, subject to case eligibility and Korean medical law.
Reach Samsung Medical Centre through My 1Health.
Share your diagnosis, relevant test results, and a brief description of your condition.
Stay durations by procedure:
There is no fixed price. Cost depends on your diagnosis, specific procedure, length of stay, and individual clinical plan. Once My 1Health submits your case and the team reviews it, a personalised estimate is prepared. An 80% deposit is required for self-pay international patients.
Samsung Medical Centre's five-year prostate cancer survival rate is 100.3% (2008 to 2022), exceeding the Korean national average of 96.5% and the US SEER benchmark of 97.9%. The hospital performed 1,254 prostate cancer surgeries in 2024. Nerve-sparing prostatectomy uses the 5th generation Da Vinci system; PSMA PET imaging supports pre-surgical staging.
The urology and oncology teams treat: